In addition, genetic studies on human AD patients have reported that BDNFVal66Met SNP, known to reduce synaptic BDNF release [90], is associated with greater cognitive impairment and higher vulnerability of hippocampus-frontal connectivity to primary AD pathology [91,92]. The gene discussed is BDNF; the disease is Alzheimer disease.